Penn researchers from the Center for Precision Surgery, along with colleagues at other institutions, will use the research grant to study and improve the intraoperative molecular imaging technology for non-small-cell lung cancers, according to a June 27 press release. Researchers aim to develop improved beacon molecules for non-small-cell lung cancers and imaging equipment to go with it. These will then be tested in clinical trials.
“This funding gives us a tremendous opportunity to further evaluate this important technology and with the goal being to improve outcomes for patients,” said Sunil Singhal MD, chief of thoracic surgery and director of the Center for Precision Surgery in the Abramson Cancer Center. “We aim to develop this technology even further and to study it in additional clinical trials to help improve surgical identification and removal of tumors.”
The clinical trials of the new technology will be conducted at Penn Medicine.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
